Cargando…
A224 USTEKINUMAB EFFECTIVENESS AND SAFETY IN PEDIATRIC PERIANAL CROHN’S DISEASE, A CASE REPORT AND LITERATURE REVIEW
BACKGROUND: Crohn’s disease (CD) is a chronic, relapsing, destructive, and inflammatory disease with penetrating, stricturing, or just inflammatory behavior that might affect the gastrointestinal tract or present with extraintestinal manifestations. Perianal fistulizing CD remains a challenging cond...
Autores principales: | Abu Abthan, M, Church, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991197/ http://dx.doi.org/10.1093/jcag/gwac036.224 |
Ejemplares similares
-
T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
por: Bertani, L., et al.
Publicado: (2022) -
A192 EFFICACY OF USTEKINUMAB IN SMALL BOWEL STRICTURES OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND
por: St-Pierre, J, et al.
Publicado: (2023) -
A212 THE IMPACT OF COMBINED MEDICAL AND SURGICAL TREATMENT FOR PERIANAL CROHN’S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Fung, M, et al.
Publicado: (2023) -
Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis
por: Godoy Brewer, Gala M, et al.
Publicado: (2021) -
Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis
por: Yao, Jiayin, et al.
Publicado: (2023)